The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Mergers & AcquisitionsMediumUpdated×2•Originally published 8 May 2026•Updated 9 May 2026•

1 min read

TOMI Reports Q1 Results and Announces Strategic Merger LOI with Carbonium Core

Key Facts

1TOMI Environmental Solutions announced a non-binding letter of intent to merge with Carbonium Core, Inc., a producer of nuclear-grade graphite.

2The company reported its financial results for the three months ended March 31, 2026.

26 days ago

Version History

Version 226 days ago

What changed: Updated the story to confirm the TOMI earnings call discussions and include the Q1 results announcement from Vaxart, Inc.

Version 126 days ago

What changed: Updated the story to include specific Q1 financial performance data, including the $0.04 EPS loss, the year-over-year loss widening, and the revenue miss against estimates, while adding the ticker TOMZ.

TOMI Environmental Solutions (TOMZ) reported its Q1 2026 financial results, posting a loss of $0.04 per share, which met analyst consensus despite widening year-over-year. During the subsequent earnings call, management detailed the non-binding letter of intent to merge with Carbonium Core, focusing on nuclear-grade graphite for AI data centers and reactors. Simultaneously, Vaxart, Inc. (VXRT) released its Q1 2026 financial results and held an earnings call to discuss its operational performance and clinical progress. TOMI's management characterized the potential merger as a transformative step into the clean energy and high-tech materials sectors. Investors are closely monitoring how these strategic shifts will offset recent revenue misses and current financial pressures. The updates from both companies highlight a broader trend of pivoting toward high-growth infrastructure and healthcare markets.